ZEPHYRx acquired by a Leading Global CRO

Aug. 2026

Client: ZEPHYRx is a leading provider of respiratory endpoint data capture and monitoring solutions for clinical trials and clinical care. The Company’s innovative software platform is highly differentiated, offering improved collection and interpretation of respiratory data, integrated eCOA / ePRO, greater interoperability with respiratory devices, and a modern software architecture that delivers high-quality data on accelerated timelines.

Role: Edgemont Partners acted as the exclusive financial advisor to ZEPHYRx in its sale to a Leading Global CRO

Location: Troy, NY

Sectors: Healthcare Technology & Services, Pharmaceutical Services & Technology

Lead Bankers: Sam Fertitta, Taylor Gillan, Omar Champsi